NEAT1 and neoplasm: For example, the combination of anti-PD1 antibody or its antigen binding fragment with drugs such as taxanes and platinum compounds can reduce the expression level of lncRNA-NEAT1, thereby increasing the sensitivity of tumor cells to immune checkpoint inhibitors and making it easier to be acknowledged and cleared by the immune system.